Brief: Novabay Pharmaceuticals Reports Second Quarter 2020 Financial Results

Stablecoin Development

06/08/2020 22:23

NovaBay Pharmaceuticals Inc  NBY.A :
    * NOVABAY PHARMACEUTICALS REPORTS SECOND QUARTER 2020
FINANCIAL
RESULTS
    * Q2 LOSS PER SHARE $0.15
    * CONFIDENT WILL RETAIN NYSE CONTINUED-LISTING COMPLIANCE
FOLLOWING OUR SUCCESSFUL ATM FINANCING
    * EXPECT FINANCIAL RESOURCES TO BE SUFFICIENT TO FUND
CURRENT
OPERATIONS THROUGH 2021
    * NET LOSS FOR Q2 WAS $0.15 PER SHARE

Source text for Eikon:  ID:nBw46hBYGa 
Further company coverage:  NBY.A